Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Concurrent Chemoradiotherapy vs Radiotherapy in Esophageal Squamous Cell Carcinoma
NCT03600831Phase 3Completed
- Start
- Aug 2018
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, cisplatin in Esophageal Squamous Cell Carcinoma (ESCC). Started Aug 2018; status: completed.
02
Drugs
docetaxelcisplatin
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT03600831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03600831.